127 related articles for article (PubMed ID: 34863996)
1. The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications.
Bailly C
Eur J Pharmacol; 2022 Jan; 914():174661. PubMed ID: 34863996
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.
Newick K; Cunniff B; Preston K; Held P; Arbiser J; Pass H; Mossman B; Shukla A; Heintz N
PLoS One; 2012; 7(6):e39404. PubMed ID: 22761781
[TBL] [Abstract][Full Text] [Related]
3. Thiostrepton Hijacks Pyoverdine Receptors To Inhibit Growth of Pseudomonas aeruginosa.
Ranieri MRM; Chan DCK; Yaeger LN; Rudolph M; Karabelas-Pittman S; Abdo H; Chee J; Harvey H; Nguyen U; Burrows LL
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262758
[No Abstract] [Full Text] [Related]
4. Thiostrepton inhibits stable 70S ribosome binding and ribosome-dependent GTPase activation of elongation factor G and elongation factor 4.
Walter JD; Hunter M; Cobb M; Traeger G; Spiegel PC
Nucleic Acids Res; 2012 Jan; 40(1):360-70. PubMed ID: 21908407
[TBL] [Abstract][Full Text] [Related]
5. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
6. Thiopeptide Antibiotics Exhibit a Dual Mode of Action against Intracellular Pathogens by Affecting Both Host and Microbe.
Zheng Q; Wang Q; Wang S; Wu J; Gao Q; Liu W
Chem Biol; 2015 Aug; 22(8):1002-7. PubMed ID: 26211364
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton.
Hegde NS; Sanders DA; Rodriguez R; Balasubramanian S
Nat Chem; 2011 Aug; 3(9):725-31. PubMed ID: 21860463
[TBL] [Abstract][Full Text] [Related]
8. Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast.
Aminake MN; Schoof S; Sologub L; Leubner M; Kirschner M; Arndt HD; Pradel G
Antimicrob Agents Chemother; 2011 Apr; 55(4):1338-48. PubMed ID: 21245445
[TBL] [Abstract][Full Text] [Related]
9. Interaction of thiostrepton and elongation factor-G with the ribosomal protein L11-binding domain.
Bowen WS; Van Dyke N; Murgola EJ; Lodmell JS; Hill WE
J Biol Chem; 2005 Jan; 280(4):2934-43. PubMed ID: 15492007
[TBL] [Abstract][Full Text] [Related]
10. Influence of thiostrepton binding on the ribosomal GTPase associated region characterized by molecular dynamics simulation.
Wolf A; Baumann S; Arndt HD; Kirschner KN
Bioorg Med Chem; 2012 Dec; 20(24):7194-205. PubMed ID: 23107668
[TBL] [Abstract][Full Text] [Related]
11. The antibiotic thiostrepton inhibits a functional transition within protein L11 at the ribosomal GTPase centre.
Porse BT; Leviev I; Mankin AS; Garrett RA
J Mol Biol; 1998 Feb; 276(2):391-404. PubMed ID: 9512711
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer.
Yang N; Zhou TC; Lei XX; Wang C; Yan M; Wang ZF; Liu W; Wang J; Ming KH; Wang BC; Xu BL; Liu Q
Cell Physiol Biochem; 2016; 38(3):1157-70. PubMed ID: 26963129
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
Jiang L; Wang P; Chen L; Chen H
Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a biologically active thiostrepton fragment.
Nicolaou KC; Zak M; Rahimipour S; Estrada AA; Lee SH; O'Brate A; Giannakakou P; Ghadiri MR
J Am Chem Soc; 2005 Nov; 127(43):15042-4. PubMed ID: 16248640
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of thiopeptide and orthosomycin antibiotics on translational GTPases.
Mikolajka A; Liu H; Chen Y; Starosta AL; Márquez V; Ivanova M; Cooperman BS; Wilson DN
Chem Biol; 2011 May; 18(5):589-600. PubMed ID: 21609840
[TBL] [Abstract][Full Text] [Related]
16. Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.
Cunniff B; Newick K; Nelson KJ; Wozniak AN; Beuschel S; Leavitt B; Bhave A; Butnor K; Koenig A; Chouchani ET; James AM; Haynes AC; Lowther WT; Murphy MP; Shukla A; Heintz NH
PLoS One; 2015; 10(5):e0127310. PubMed ID: 26011724
[TBL] [Abstract][Full Text] [Related]
17. FoxM1 inhibitors as potential anticancer drugs.
Gartel AL
Expert Opin Ther Targets; 2008 Jun; 12(6):663-5. PubMed ID: 18479213
[TBL] [Abstract][Full Text] [Related]
18. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
[TBL] [Abstract][Full Text] [Related]
19. Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton.
Nelson KJ; Messier T; Milczarek S; Saaman A; Beuschel S; Gandhi U; Heintz N; Smalley TL; Lowther WT; Cunniff B
Antioxidants (Basel); 2021 Jan; 10(2):. PubMed ID: 33498547
[TBL] [Abstract][Full Text] [Related]
20. Interactions of the N-terminal domain of ribosomal protein L11 with thiostrepton and rRNA.
Bausch SL; Poliakova E; Draper DE
J Biol Chem; 2005 Aug; 280(33):29956-63. PubMed ID: 15972821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
